| Bioactivity | (2R,3S,5R)-2-(hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3-ol (9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine |
| CAS | 16006-64-7 |
| Formula | C12H15N3O3 |
| Molar Mass | 249.27 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpurine
CAS: 16006-64-7 F: C12H15N3O3 W: 249.27
(2R,3S,5R)-2-(hydroxymethyl)-5-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3-ol (9-(2-Deoxy-beta-D-ribofuranosyl)-6-methylpu
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.